EUVIMEDEUVIMED entdecken
Editorial

Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients

Beatrice Z Sim iD, Monica A Slavin iD, Abby P Douglas iD

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14102 ↗

Kurz gefasst

Editorial in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Beatrice Z Sim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Anti-Infective Agents, Bacteremia, Leukemia, Myeloid, Acute, Gram-Negative Bacterial Infections. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MAS has been awarded grants from Gilead, Merck, and F2G, as well as honoraria from F2G, Pfizer, Merck, Takeda, and Gilead, and is on the data review/advisory boards of Pfizer, F2G, Cidara, Takeda, and Roche with all payments to an institution. APD has been awarded a grant and honoraria from Gilead, with all payments to an institution. BZS has no disclosures. Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsBacteremiaLeukemia, Myeloid, AcuteGram-Negative Bacterial InfectionsHumansAnti-Bacterial AgentsGram-Negative Bacteria

Substanzen

Anti-Infective AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia.

ORCID-Profile: Beatrice Z Sim, Monica A Slavin, Abby P Douglas

Zitieren

APA

Sim, B. Z., Slavin, M. A., & Douglas, A. P. (2023). Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14102

Vancouver

Sim BZ, Slavin MA, Douglas AP. Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients. Transplant Infectious Disease. 2023. doi:10.1111/tid.14102

BibTeX
@article{Sim2023,
  author = {Sim, Beatrice Z and Slavin, Monica A and Douglas, Abby P},
  title = {Risky business: The impact of antimicrobial prescribing on multidrug‐resistant Gram‐negative BSIs in acute myeloid leukemia patients},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14102}
}
Kostenlos starten →